School of Medicine


Showing 101-150 of 170 Results

  • Kenton Anderson

    Kenton Anderson

    Clinical Associate Professor, Emergency Medicine

    Current Research and Scholarly InterestsCardiopulmonary Resuscitation
    Cardiac Arrest
    Emergency Ultrasound

  • Rodney U. Anderson, MD FACS

    Rodney U. Anderson, MD FACS

    Professor (Clinical) of Urology, Emeritus

    Current Research and Scholarly InterestsClinical Medical Research devoted to tertiary level application of treatment modalities for neurologic and functional disturbances of the genitourinary tract. Problems such as urinary incontinence, urinary retention, urinary flow dysfunction (BPH), impotence, and chronic pelvic pain syndromes are addressed. New medical devices and technology for treating these disorders are investigated

  • Thomas Anthony ("Tony") Anderson

    Thomas Anthony ("Tony") Anderson

    Clinical Professor, Anesthesiology, Perioperative and Pain Medicine

    Current Research and Scholarly InterestsMy lab's research focuses on two areas:
    1. Focused ultrasound for peripheral nervous system modulation- We are interested in the potential of focused ultrasound to modulate peripheral nerves and improve both acute and chronic pain.
    2. Pediatric perioperative outcomes- Our goals are to understand A) how various perioperative pain management strategies affect outcomes in children who undergo surgery and B) whether disparities in the perioperative pain management of children occur.

  • Kazuo Ando

    Kazuo Ando

    Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine

    BioBorn and raised in Japan, Dr. Ando received an MD-PhD degree from the Aichi Medical University. After anesthesia training, Dr. Ando came to Stanford to pursue clinical and basic research experience. During his postdoctoral fellowship in Dr. Gaudilliere's laboratory, Dr. Ando worked on publication of “A next-generation single-cell technology (mass cytometry) to study the feto-maternal immune system,” a project designed to evaluate the immune response associated with preterm birth. In addition, Dr. Ando performs research in Obstetric Anesthesia, such as respiratory monitoring after cesarean sections and labor satisfaction, to obtain clinical research experience and to understand the key differences in medicine between the United States and Japan.
    After his postdoctoral fellowship, Dr. Ando has maintained his status as a researcher in Dr. Gaudilliere's laboratory, continuing work relating to pregnancy and preterm birth.
    Dr. Ando divides his efforts between laboratory research and the clinic.

  • Katrin Andreasson

    Katrin Andreasson

    Edward F. and Irene Thiele Pimley Professor of Neurology and Neurological Sciences

    Current Research and Scholarly InterestsOur research focuses on understanding how immune responses initiate and accelerate synaptic and neuronal injury in age-related neurodegeneration, including models of Alzheimer's disease and Parkinson's disease. We also focus on the role of immune responses in aggravating brain injury in models of stroke. Our goal is the identification of critical immune pathways that function in neurologic disorders and that can be targeted to elicit disease modifying effects.

  • Jason Andrews

    Jason Andrews

    Professor of Medicine (Infectious Diseases)

    Current Research and Scholarly InterestsOur laboratory aims to develop and test innovative approaches to the diagnosis, treatment and control of infectious diseases in resource-limited settings. We draw upon multiple fields including mathematical modeling, microbial genetics, field epidemiology, statistical inference and biodesign to work on challenging problems in infectious diseases, with an emphasis on tuberculosis and tropical diseases.

  • Lay Teng Ang

    Lay Teng Ang

    Instructor, Institute for Stem Cell Biology and Regenerative Medicine

    BioAs a stem cell biologist, I aim to understand the mechanisms through which stem cells differentiate into progressively specialized cell types and to harness this knowledge to artificially generate pure populations of desired cell types from stem cells. My work over the past ten years has centered on pluripotent stem cells (PSCs, which include embryonic and pluripotent stem cells), which can generate any of the hundreds of diverse cell types in the body. However, it has been notoriously challenging to guide PSCs to differentiate into a pure population of a given cell type. Current differentiation strategies typically generate heterogeneous cell populations unsuitable for basic research or clinical applications. To address this challenge, I mapped the cascade of branching lineage choices through which PSCs differentiate into various endodermal and mesodermal cell types. I then developed effective methods to differentiate PSCs into specific lineages by providing the extracellular signal(s) that specify a given lineage while inhibiting the signals that induce the alternate fate(s), enabling the generation of highly-pure human heart and bone (Loh & Chen et al., 2016; Cell) and liver (Loh & Ang et al., 2014; Cell Stem Cell) from PSCs. My laboratory currently focuses on differentiating human PSCs into liver progenitors (Ang et al., 2018; Cell Reports) and blood vessel cells (Ang et al., 2022; Cell).

    I earned my Ph.D. jointly from the University of Cambridge and A*STAR and was subsequently appointed as a Research Fellow and, later, a Senior Research Fellow at the Genome Institute of Singapore. I then moved my laboratory to Stanford University as a Siebel Investigator and Instructor at the Stanford Institute for Stem Cell Biology & Regenerative Medicine. My laboratory has been supported by the Siebel Investigatorship, California Institute for Regenerative Medicine, and other sources.

  • Michael Angelo

    Michael Angelo

    Associate Professor of Pathology

    BioMichael Angelo, MD PhD is a board-certified pathologist and assistant professor in the department of Pathology at Stanford University School of Medicine. Dr. Angelo is a leader in high dimensional imaging with expertise in tissue homeostasis, tumor immunology, and infectious disease. His lab has pioneered the construction and development of Multiplexed Ion Beam Imaging by time of flight (MIBI-TOF). MIBI-TOF uses secondary ion mass spectrometry and metal-tagged antibodies to achieve rapid, simultaneous imaging of dozens of proteins at subcellular resolution. In recognition of this achievement, Dr. Angelo received the NIH Director’s Early Independence award in 2014. His lab has since used this novel technology to discover previously unknown rule sets governing the spatial organization and cellular composition of immune, stromal, and tumor cells within the tumor microenvironment in triple negative breast cancer. These findings were found to be predictive of single cell expression of several immunotherapy drug targets and of 10-year overall survival. This effort has led to ongoing work aimed at elucidating structural mechanisms in the TME that promote recruitment of cancer associated fibroblasts, tumor associated macrophages, and extracellular matrix remodeling. Dr. Angelo is the recipient of the 2020 DOD Era of Hope Award and a principal investigator on multiple extramural awards from the National Cancer Institute, Breast Cancer Research Foundation, Parker Institute for Cancer Immunotherapy, the Bill and Melinda Gates Foundation, and the Human Biomolecular Atlas (HuBMAP) initiative.

  • Timothy Angelotti MD, PhD

    Timothy Angelotti MD, PhD

    Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine

    Current Research and Scholarly InterestsMy research efforts are focused on investigating the pharmacological and physiological interface of the autonomic nervous system with effector organs. Utilizing molecular, cellular, and electrophysiological techniques, we are examining alpha2 adrenergic receptor function in cultured sympathetic neurons. Future research aims will be directed toward understanding neurotransmitter release in general.

  • Martin S. Angst

    Martin S. Angst

    Professor of Anesthesiology, Perioperative and Pain Medicine
    On Partial Leave from 03/21/2024 To 04/19/2024

    Current Research and Scholarly InterestsOur laboratory studies biological and clinical determinants of human resilience using surgery as an injury model.

  • Justin P. Annes M.D., Ph.D.

    Justin P. Annes M.D., Ph.D.

    Associate Professor of Medicine (Endocrinology)

    Current Research and Scholarly InterestsThe ANNES LABORATORY of Molecular Endocrinology: Leveraging Chemical Biology to Treat Endocrine Disorders

    DIABETES
    The prevalence of diabetes is increasing at a staggering rate. By the year 2050 an astounding 25% of Americans will be diabetic. The goal of my research is to uncover therapeutic strategies to stymie the ensuing diabetes epidemic. To achieve this goal we have developed a variety of innovate experimental approaches to uncover novel approaches to curing diabetes.

    (1) Beta-Cell Regeneration: Diabetes results from either an absolute or relative deficiency in insulin production. Our therapeutic strategy is to stimulate the regeneration of insulin-producing beta-cells to enhance an individual’s insulin secretion capacity. We have developed a unique high-throughput chemical screening platform which we use to identify small molecules that promote beta-cell growth. This work has led to the identification of key molecular pathways (therapeutic targets) and candidate drugs that promote the growth and regeneration of islet beta-cells. Our goal is to utilize these discoveries to treat and prevent diabetes.

    (2) The Metabolic Syndrome: A major cause of the diabetes epidemic is the rise in obesity which leads to a cluster of diabetes- and cardiovascular disease-related metabolic abnormalities that shorten life expectancy. These physiologic aberrations are collectively termed the Metabolic Syndrome (MS). My laboratory has developed an original in vivo screening platform t to identify novel hormones that influence the behaviors (excess caloric consumption, deficient exercise and disrupted sleep-wake cycles) and the metabolic abnormalities caused by obesity. We aim to manipulate these hormone levels to prevent the development and detrimental consequences of the MS.

    HEREDIATY PARAGAGLIOMA SYNDROME
    The Hereditary Paraganglioma Syndrome (hPGL) is a rare genetic cancer syndrome that is most commonly caused by a defect in mitochondrial metabolism. Our goal is to understand how altered cellular metabolism leads to the development of cancer. Although hPGL is uncommon, it serves as an excellent model for the abnormal metabolic behavior displayed by nearly all cancers. Our goal is to develop novel therapeutic strategies that target the abnormal behavior of cancer cells. In the laboratory we have developed hPGL mouse models and use high throughput chemical screening to identify the therapeutic susceptibilities that result from the abnormal metabolic behavior of cancer cells.

    As a physician scientist trained in clinical genetics I have developed expertise in hereditary endocrine disorders and devoted my efforts to treating families affected by the hPGL syndrome. By leveraging our laboratory expertise in the hPGL syndrome, our care for individuals who have inherited the hPGL syndrome is at the forefront of medicine. Our goal is to translate our laboratory discoveries to the treatment of affected families.

  • Arash Anoshiravani

    Arash Anoshiravani

    Clinical Associate Professor, Pediatrics - Adolescent Medicine

    Current Research and Scholarly InterestsResearch interests include high-risk youth, adolescent health services, and the juvenile justice system.

  • David Ansel

    David Ansel

    Clinical Associate Professor, Pediatrics

    BioI graduated from UCLA (now Geffen) School of Medicine, did my pediatrics residency at Columbia-Presbyterian in NYC, followed by a clinical fellowship in developmental (what was then called an “ambulatory”) pediatrics at Boston Children’s Hospital. The first 28 years of my career were spent in clinical practice combining both DBP and primary care (the latter focused on serving CSHCN). During those years I was involved in numerous divide-bridging efforts - including programs to coordinate inpatient & outpatient medicine, connect tertiary & primary care, and promote teamwork between pediatricians, psychologists, nurse practitioners, and other community partners. I founded my own solo practice in 1989 and managed its growth to an 8-provider group over the next 25 years. Our practice was a founding member of the PPOC and I served on its board of directors for 6 years. The PPOC is one of the largest pediatric IPA’s in the country, with >200 member providers affiliated with Boston Children's Hospital. Over the years we were involved in groundbreaking QI initiatives including those involving asthma, weight, and ADHD management; medical home; and behavioral health integration with primary care.

    I’m now well into my career's “second act” on the clinician-educator track here at Stanford. I'm proud to have piloted our division's primary care initiative (DBPCI) and am now in the process of planning for a second phase thereof, hoping to make improved collaboration between DBP and primary care more available to more patients. I also pioneered the use of telehealth in our division, and then helped guide its sudden widespread adoption by my peers during the COVID-19 crises. Looking forward, I expect what we have learned during the pandemic will inform what we do for DBPCI 2.0.

  • Eric Appel

    Eric Appel

    Associate Professor of Materials Science and Engineering, Senior Fellow at the Woods Institute for the Environment and Associate Professor, by courtesy, of Pediatrics (Endocrinology)

    Current Research and Scholarly InterestsThe underlying theme of the Appel Lab at Stanford University integrates concepts and approaches from supramolecular chemistry, natural/synthetic materials, and biology. We aim to develop supramolecular biomaterials that exploit a diverse design toolbox and take advantage of the beautiful synergism between physical properties, aesthetics, and low energy consumption typical of natural systems. Our vision is to use these materials to solve fundamental biological questions and to engineer advanced healthcare solutions.

  • Sally Arai

    Sally Arai

    Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

    Current Research and Scholarly InterestsResearch interest in utilizing post-transplant adoptive cellular immunotherapy to reduce GVHD and relapse in patients with high risk hematologic malignancies.

  • Amin Arbabian

    Amin Arbabian

    Associate Professor of Electrical Engineering

    Current Research and Scholarly InterestsMy group's research covers RF circuits and system design for (1) biomedical, (2) sensing, and (3) Internet of Things (IoT) applications.

  • Ronald L. Ariagno

    Ronald L. Ariagno

    Professor (Clinical) of Pediatrics, Emeritus

    Current Research and Scholarly InterestsDevelopmental Physiology and Sudden Infant Death Syndrome Research Laboratory closed in 2008.

    Current effort, as Chair of Task Force and neonatal consult at the FDA, is to establish through consensus a culture of investigation and collaboration for all clinical neonatology practices: academic, corporate and community based to maximize the opportunity to participate in research effort needed for the regulatory approval of neonatal therapeutics to improve the outcome of critically ill infants.

  • Danit Ariel

    Danit Ariel

    Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism

    BioDanit Ariel, MD MS, is board certified in Endocrinology. Dr. Ariel graduated from UC Davis School of Medicine. She then completed a residency in Internal Medicine at Stanford and a fellowship and post-doctorate in Endocrinology and Metabolism at Stanford before joining the faculty at Stanford.

    Dr. Ariel practices general endocrinology, with a special interest in menopause, LGBTQ+ health, transgender medicine, reproductive endocrinology and thyroid disorders amongst others.

    She believes in practicing compassionate care: in listening to her patients’ concerns, respecting their values, communicating well, and providing an evidence-based approach to help guide individualized treatment plans. She is deeply committed to utilizing her expertise in the field of endocrinology to optimize her patients’ health and well-being.

    Dr. Ariel is passionate about medical education and teaching, and serves on the teaching faculty in the Stanford University School of Medicine. She completed an honors certificate in medical education from Stanford. She is the Founding Director of the Student Guidance Program for medical students. Finally, within the division of Endocrinology, she is the Director of Faculty Wellness.

    Appointments with with Dr. Ariel are available in the Hoover Pavilion on 211 Quarry Road as part of the Stanford Health Care Endocrinology Clinic and the Stanford Health Care LGBTQ+ Health Program.

  • Nicole E Arkin

    Nicole E Arkin

    Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine

    BioI am a critical care anesthesiologist who is devoted to providing excellent clinical care for the sickest patients and their families as well as training our next generation of leaders in critical care medicine.

    The ICU is a unique and fascinating world where I get to combine my love of abnormal physiology, teaching, high-stakes medical care, interdisciplinary collaboration, and deep connections with patients and families. As an intensivist, anesthesiologist, and medical educator, there is no place where this is truer than at Stanford. After completing both medical school and anesthesiology residency at Stanford, I experienced the ravages of the COVID-19 pandemic along with the innovation and collaboration that can result from moments of crisis as an Critical Care Medicine fellow at Massachusetts General Hospital. I was drawn to return to Stanford to join our incredible group of intensivists based on the emphasis on interdisciplinary collaboration and professional growth. This rich environment is filled with interesting medicine and brilliant colleagues; it is a place that supports my goals of educating and training future leaders in critical care medicine while taking care of the sickest patients in the hospital and their families.

    While clinical practice is the foundation of what I love about being a physician, I am also interested in leadership development both through education and research. I have a Masters of Science in Teaching and spent two years as a high school chemistry teacher in the South Bronx through Teach for America where I focused on curriculum development. In residency, I became interested in feedback and led a mixed methods research study that identified gender bias in resident feedback during the early years of anesthesiology residency. Currently, I am the Associate Program Director of our Anesthesia Critical Care fellowship and am the Director of the required clerkship for medical students in the ICU. I feel incredibly privileged to work in a place that supports these pursuits and encourages me to be the best physician, colleague, and educator I can be.

  • James Armontrout

    James Armontrout

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    BioDr. Armontrout is the Program Director of the Stanford Forensic Psychiatry Fellowship. He completed residency training at the Harvard Longwood Psychiatry Residency Training Program, followed by forensic psychiatry fellowship at the University of California, San Francisco. He is board certified in Psychiatry, Forensic Psychiatry, and Addiction Medicine.

    Before coming to Stanford Dr. Armontrout worked as a staff psychiatrist for the Palo Alto VA Healthcare System at the Trauma Recovery Program, a residential treatment program focusing on PTSD, other trauma-related disorders, and substance use disorders. For a portion of Dr. Armontrout's time with the VA he served as the Medical Director for the Trauma Recovery Program.

    In addition to his forensic fellowship activities, Dr. Armontrout currently serves as an attending in the Stanford PTSD clinic and the dual diagnosis clinic.

  • Bruce Arnow, Ph.D.

    Bruce Arnow, Ph.D.

    Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult)

    Current Research and Scholarly InterestsCurrent research interests include treatment outcome for major depression, particularly treatment refractory and chronic forms of major depression, as well as mediators and moderators of outcome; the epidemiology of chronic pain and depression; relationships between child maltreatment and adult sequelae, including psychiatric, medical and health care utilization.

  • Anna Chen Arroyo

    Anna Chen Arroyo

    Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    BioDr. Arroyo specializes in the treatment of allergic conditions including drug allergy and asthma. She has a special interest in understanding health and healthcare disparities in allergic diseases and how allergies change over a person's lifetime.

  • Maja Artandi, MD

    Maja Artandi, MD

    Clinical Professor, Medicine - Primary Care and Population Health

    BioDr. Artandi is a Professor of Medicine in the Division of Primary Care and Population Health at Stanford. She is a leader in Primary Care, spearheading novel methods of health care delivery and education. She offers an impressive clinical background and has received several educational and leadership awards.
    Her expertise lies in the development and implementation of a medical curriculum focused on the patient-physician interaction, emphasizing communication skills, physical examination skills and medical decision making to support best clinical practices.
    Dr. Artandi is a dedicated Primary Care physician and educator and has served as a mentor for many students, residents and colleagues. She is currently the mentorship lead for the Division of Primary Care and Population Health.
    She is in the process of getting an executive coaching certification and is faculty for the Advancing Communication Excellence at Stanford Program with the goal of helping her colleagues improve their communication skills.
    From 2013-2021 she was the Co-Director of Primary Care education for the Stanford Internal Medicine residency program and co-founded and co-directed the Primary Care program (ACE) within the Stanford Internal Medicine Residency program.
    Dr. Artandi is currently the Co-President of the Society of Bedside Medicine, an international society dedicated to studying and improving the patient/physician interaction.
    She is a fellow of the Royal College of Physicians Edinburgh and of the American College of Physicians and currently serves as the Wellness chair for the Northern California ACP chapter.

  • Steven Artandi, MD, PhD

    Steven Artandi, MD, PhD

    Laurie Kraus Lacob Director of the Stanford Cancer Institute (SCI), Jerome and Daisy Low Gilbert Professor and Professor of Biochemistry

    Current Research and Scholarly InterestsTelomeres are nucleoprotein complexes that protect chromosome ends and shorten with cell division and aging. We are interested in how telomere shortening influences cancer, stem cell function, aging and human disease. Telomerase is a reverse transcriptase that synthesizes telomere repeats and is expressed in stem cells and in cancer. We have found that telomerase also regulates stem cells and we are pursuing the function of telomerase through diverse genetic and biochemical approaches.

  • Alisa Arunamata

    Alisa Arunamata

    Clinical Associate Professor, Pediatrics - Cardiology

    BioDr. Alisa Arunamata is a pediatric cardiologist and Clinical Associate Professor in the Department of Pediatrics at Stanford University School of Medicine. She specializes in cardiac imaging of the fetus through adulthood and provides comprehensive care to families and patients from the time of fetal diagnosis to post-operative management after cardiac surgery. She holds a number of leadership positions in education and hospital administration. She leads the pediatric cardiology fellowship training program as the Director, and was previously the Program Director of the Advanced Non-Invasive Imaging Fellowship as well as the Medical Director of Acute Cardiac Care at Lucile Packard Children's Hospital at Stanford.

    Dr. Arunamata has a deep interest in improving clinical outcomes for children with congenital and acquired heart disease, with a primary focus on refining the assessment and contribution of the right ventricle in disease and health.

    She graduated early with a degree in Molecular and Cell Biology (Biochemistry) from the University of California, Berkeley, obtained her medical degree at New York University School of Medicine and completed pediatric residency and cardiology fellowship training at Stanford. She was elected to the Alpha Omega Alpha Medical Honor Society in 2019 and is a Fellow of the American College of Cardiology (FACC) and American Society of Echocardiography (FASE).

  • Ann M. Arvin

    Ann M. Arvin

    Lucile Salter Packard Professor of Pediatrics and Professor of Microbiology and Immunology, Emerita

    Current Research and Scholarly InterestsOur laboratory investigates the pathogenesis of varicella zoster virus (VZV) infection, focusing on the functional roles of particular viral gene products in pathogenesis and virus-cell interactions in differentiated human cells in humans and in Scid-hu mouse models of VZV cell tropisms in vivo, and the immunobiology of VZV infections.

  • Shipra Arya

    Shipra Arya

    Professor of Surgery (Vascular Surgery)

    BioShipra Arya, MD SM FACS is a Professor of Surgery at the Stanford University School of Medicine and section chief of vascular surgery at VA Palo Alto Healthcare System. She has a Master’s degree in epidemiology from the Harvard School of Public Health with focus on research methodology and cardiovascular epidemiology. She completed her General Surgery Residency at Creighton University Medical Center followed by a Vascular Surgery Fellowship at University of Michigan. She has been funded by American Heart Association (AHA), NIH/NIA GEMSSTAR grant, VA Palo Alto Center for Innovation and Implementation (Ci2i), and is currently funded by VA HSR&D for a multicenter stepped wedge cluster randomized clinical trial called “PAtient-centered mUltidiSciplinary Care for vEterans Undergoing Surgery (PAUSE) trial”. Her current work focuses on streamlining frailty evaluation, as well as implementation of patient and system level interventions to improve surgical quality and to provide high-value and patient centered care.

    She has multiple administrative roles in surgical quality improvement as Director of Surgical Quality at VAPAHCS; Center director for Stanford University in the Vascular Quality Initiative (VQI); and the Associate Medical Director of the Northern California region for VQI, which is the national registry database and patient safety organization for Society for Vascular Surgery (SVS). Her involvement in SVS VQI also extends to being a member of the steering committee of the Vascular Implant Surveillance and Interventional Outcomes Network (VISION) to improve the quality, safety and effectiveness of vascular care. She also serves as the President of the Surgical Outcomes Club, a national organization of surgical health services researchers, and chairs multiple national committees: VA surgeons committee for the SVS and Diversity and Inclusion Committee for the Association of VA surgeons.

  • Steven Asch

    Steven Asch

    Professor of Medicine (Primary Care and Population Health) and, by courtesy, of Health Policy

    Current Research and Scholarly InterestsDescribe your current research interest and activities

  • Ryan T. Ash MD, PhD

    Ryan T. Ash MD, PhD

    Instructor, Psychiatry and Behavioral Sciences

    BioMy lab is interested in developing novel neuromodulation technologies to augment neuroplasticity and enhance the "unlearning" of maladaptive habitual ways of relating to the to the world. I have a K08 Career Development Award to measure how attention modulates neuroplasticity induced by repetitive transcranial magnetic stimulation, using EEG steady-state visual evoked potentials and visual attention psychophysics. I have a Brain Behavior Research Foundation Young Investigator Award to develop in-human applications of transcranial ultrasound stimulation in the subcortical visual system and fear regulation circuit. I have a Simons Foundation Bridge to independence Award to develop closed-loop ultrasound neuromodulation technologies to enhance behavioral flexibility in autism spectrum disorders. I work closely with mentors Anthony Norcia, Kim Butts Pauly, and Nolan Williams on these projects. I am interested in the neural basis of mindfulness, concentration, and compassion practices from Buddhist meditation, and I have more than a year of silent retreat experience in the Theravada Buddhist meditation tradition. I see patients in the Stanford Neuropsychiatry clinic with a specialization in Functional Neurological disorders and related psychosomatic and dissociative conditions. My therapeutic orientations include integrated psychodynamic- and mindfulness-based approaches and neuromodulation-assisted psychotherapy.

  • Euan A. Ashley

    Euan A. Ashley

    Associate Dean, School of Medicine, Roger and Joelle Burnell Professor of Genomics and Precision Health, Professor of Medicine (Cardiovascular Medicine), of Genetics, of Biomedical Data Science and, by courtesy, of Pathology

    Current Research and Scholarly InterestsThe Ashley lab is focused on precision medicine. We develop methods for the interpretation of whole genome sequencing data to improve the diagnosis of genetic disease and to personalize the practice of medicine. At the wet bench, we take advantage of cell systems, transgenic models and microsurgical models of disease to prove causality in biological pathways and find targets for therapeutic development.

  • Ritu Asija

    Ritu Asija

    Clinical Professor, Pediatrics - Cardiology

    BioI specialize in providing cardiac critical care to infants, children and adults with congenital heart disease and heart failure. I am the Associate Director for the Pulmonary Artery Reconstruction Program at Stanford, helping to coordinate comprehensive multidisciplinary care for children with severe pulmonary artery abnormalities and right ventricular dysfunction. I was a Faculty Fellow at the Stanford Center for Biodesign in 2019-2020 and continue to work on development of new technologies for the unmet needs of pediatric patients. I have an interest in physician wellness and completed the Wellness Director course through the WellMD Center at Stanford.

  • Themistocles (Tim) Assimes

    Themistocles (Tim) Assimes

    Associate Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsGenetic Epidemiology, Genetic Determinants of Complex Traits related to Cardiovasular Medicine, Coronary Artery Disease related pathway analyses and integrative genomics, Mendelian randomization studies, risk prediction for major adverse cardiovascular events, cardiovascular medicine related pharmacogenomics, ethnic differences in the determinants of Insulin Mediated Glucose Uptake, pharmacoepidemiology of cardiovascular drugs & outcomes

  • Diana Atashroo

    Diana Atashroo

    Clinical Associate Professor, Obstetrics & Gynecology

    BioDr. Diana Atashroo is coming to Stanford Hospital from NorthShore UniversityHealthSysteml in Illinois, affiliated with the the University of Chicago-Pritzker School of Medicine.

    Dr. Atashroo sees patients for general gynecology and a variety of other complex gynecologic issues. Her expertise includes evaluation and management of complex pelvic pathology and pelvic pain. Her special interests include: pudendal neuralgia and other peripheral neuropathic pain conditions, pelvic floor muscle spasms, vulvodynia, pelvic congestion syndrome, endometriosis, and interstitial cystitis. She also performs minimally-invasive gynecologic surgery, including laparoscopic and robotic procedures. She has special skills in ultrasound-guided peripheral nerve blocks, office procedures, and Botox trigger point injections.

    She has leadership roles within AAGL (American Association of Gynecologic Laparoscopists) and IPPS (International Pelvic Pain Society) and has presented on various topics related to pelvic pain.

    Dr. Atashroo is committed to furthering the well-being of women, and strives to provider her patients with an individualized and comprehensive approach.